Today Bjond, Inc. announced that it closed $3.25 million in Series A financing. Draper Triangle Ventures led the round, joined by co-investors TriStar Technology Ventures and Hopen Life Science Ventures.
With a chilly start to spring many families are breaking out their fire pits or starting bonfires to recover from cabin fever and start enjoying being outside. Though fire pits and campfires are a great way to connect with friends and family they also can be dangerous to adults and kids.
The U.S. Food and Drug Administration (FDA) has approved the first naloxone treatment specifically designed to be given by family members or caregivers to treat a person with opioid overdose.
Autocam Corp is a leading precision manufacturer for both the automotive and medical industries and recently announced it is sponsoring Governor Rick Snyder's Governor's Education Summit taking place on April 24, 2014. Autocam is committed to investment in education, jobs creation and advanced manufacturing technologies.
Researchers at the University of California, San Diego School of Medicine have found that too little or too much of an enzyme called SRPK1 promotes cancer by disrupting a regulatory event critical for many fundamental cellular processes, including proliferation.
Recovering from a brain injury involves a great deal of hard work, and some of that work includes finding ways to enjoy life again.
Bend Memorial Clinic (BMC) has joined the Seattle Cancer Care Alliance (SCCA) Network to become its tenth affiliate in the greater Northwest. The affiliation will expand local access to cancer treatment options and help foster advances in cancer care.
Techne Corporation, d/b/a Bio-Techne, announced today that it has made a $10 million equity investment in CyVek, Inc. (CyVek), with a commitment to acquire CyVek if certain future milestones are met.
Transgenomic, Inc., a global biotechnology company advancing personalized medicine in cardiology, oncology, and inherited diseases through diagnostic tests as well as clinical and research services, today announced an agreement with Raptor Pharmaceuticals Inc. to provide genetic testing services for Raptor's clinical trial (RP103-MITO-001) evaluating RP103 as a potential treatment for Leigh syndrome and other inherited mitochondrial disorders.
Sanford-Burnham Medical Research Institute will present a wide range of new research data at the annual American Association for Cancer Research Meeting in San Diego starting Saturday, April 5, at the San Diego Convention Center. The presentations will cover a variety of topics including breast, melanoma, and prostate cancer, as well as novel methods of delivering drugs to tumors.
President of Ireland, Michael D. Higgins, has today received three recipients of the Science Foundation Ireland, President of Ireland Young Researcher Award (PIYRA) at áras an Uachtaráin.
During birth, the baby has to stop depending on the placenta and start breathing on his or her own. If there are problems during the birth process, the baby may spend a period of time in the pathological condition of asphyxia, where the oxygen levels in the blood are much lower and carbon dioxide levels are much higher than expected.
This year's World Health Day (April 7th) focuses on vector-borne diseases, like malaria. Malaria still kills more than half a million people every year, mainly children. In the battle against this disease researchers in Switzerland have developed a new eco repellent that stops mosquitoes from attacking humans.
President Barack Obama continued to tout the success of the health care law, using the momentum to attack the House GOP's new budget proposal, as well as providing a blueprint for the defense of the law for Democrats in upcoming elections.
Dyax Corp. today announced that the U.S. Food and Drug Administration (FDA) has approved an expansion of the indication for KALBITOR (ecallantide), a peptide inhibitor of plasma kallikrein used in the treatment of acute hereditary angioedema (HAE) attacks, to include patients 12 years of age and older.
Harvard stem cell scientists have discovered that a recently approved medication for epilepsy may possibly be a meaningful treatment for amyotrophic lateral sclerosis (ALS)-Lou Gehrig's disease, a uniformly fatal neurodegenerative disorder. The researchers are now collaborating with Massachusetts General Hospital to design an initial clinical trial testing the safety of the treatment in ALS patients.
Bruno Giros, PhD, a researcher at the Douglas Mental Health University Institute and a professor in the Department of Psychiatry at McGill University, has demonstrated, for the first time, the role that dopamine plays in a region of the brain called the hippocampus.
The information will include data on what services doctors used, the average amount they charged Medicare and what they were paid. Doctors have fought such disclosures in the past.
United Recovery Systems, a portfolio company of Audax Private Equity, announced it has completed the acquisition of Array Services Group. Array, headquartered in Sartell, MN, is a leading regionally-focused provider of revenue cycle management, receivables management, and call center services to hospitals, healthcare systems, retail businesses, and financial service institutions.
Cognitive dysfunction has direct and indirect effects on healthcare costs in patients with schizophrenia, research suggests.